Login / Signup

[Therapy of moderate cognitive impairment in the early recovery period of ischemic stroke].

A N BelovaEnver I BogdanovI A VoznjoukV A ZhadnovP R KamchatnovOlga KurushinaN N Maslova
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)
Prospecta is an effective and safe treatment option for patients with moderate cognitive impairment in the early recovery period of ischemic stroke.
Keyphrases
  • cognitive impairment
  • atrial fibrillation
  • high intensity
  • stem cells
  • mesenchymal stem cells
  • bone marrow